No Data
Tianjin Tianyao Pharmaceuticals Co., Ltd.'s (SHSE:600488) Prospects Need A Boost To Lift Shares
Tianjin Tianyao Pharmaceuticals (600488.SH): A subsidiary's products are expected to be selected in the national pharmaceutical centralized procurement.
On December 16, Gelonghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its controlling subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as "Tianyan Heping"), participated in the tenth round of nationwide centralized pharmaceutical procurement organized by the Joint Procurement Office (referred to as "Joint Procurement Office"), with four products: aminophylline injection, fluorouracil injection, methoxamine injection, and methoxamine hydrochloride injection expected to be selected for this centralized procurement.
Tianjin Tianyao Pharmaceuticals Gets China Nod for Autoimmune Anti-Inflammatory Injection
Tianjin Tianyao Pharmaceuticals (600488.SH): Betamethasone phosphate injection has obtained the pharmaceutical registration certificate.
On November 28, Gelonghui reported that tianjin tianyao pharmaceuticals (600488.SH) announced that its subsidiary tianjin tianyao heping pharmaceutical co., ltd. received the "Pharmaceutical Registration Certificate" approved and issued by the National Medical Products Administration for sodium betamethasone injection. Sodium betamethasone injection is mainly used for allergic and autoimmune inflammatory diseases. It is now commonly used for active rheumatic diseases, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, severe dermatitis, acute leukemia, etc., and is also used for the comprehensive treatment of certain infections.
tianjin tianyao pharmaceuticals (600488.SH): Potassium chloride injection passed the generic drug consistency evaluation.
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Hubei Tianyao Pharmaceuticals Co., Ltd. (abbreviated as '...')
Tianjin Tianyao Pharmaceuticals (600488.SH): Over 60% of the company's steroid active pharmaceutical ingredients are exported.
On November 12, tianjin tianyao pharmaceuticals (600488.SH) stated at the performance briefing that currently, the company's active pharmaceutical ingredient products sales have covered more than 70 countries and regions globally including North and South America, Asia, and Europe. The process technology and product quality of some varieties have reached the international advanced level, making it a research, production, and export base for Asian steroid hormone drugs. Over 60% of the company's steroid hormone active pharmaceutical ingredients are exported.
Earnings Not Telling The Story For Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE:600488)
No Data
